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Abstract 
In developed and developing countries, the aging population growth rapidly and the consumption of natural 
product which rich antioxidant increasing. The aim of this study was to investigate the ABTS reducing activity 
and anti-collagenase activity of scutellarein and apigenin. This study used ABTS reducing activity for 
antioxidant assay and collagenase inhibitory activity for antiaging assay. Scutellarein (16.77 μg/ml) has higher 
antioxidant activity through ABTS reducing activity compared with apigenin (80.19 μg/ml). Scutellarein (99.20 
μg/ml) has higher antiaging activity through collagenase inhibitory activity compared with apigenin (211.67 
μg/ml). Scutellarein has very strong antioxidant activity through ABTS reduction activity and strong antiaging 
property particularly as collagenase inhibitor. Apigenin has strong antioxidant activity through ABTS reduction 
activity and weak antiaging property particularly as collagenase inhibitor. 
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1. Introduction 
In the 20th century, the aging population is growing rapidly both in developed and developing countries [1]. The 
skin aging process is developed from a combination of intrinsic aging (age-related) and extrinsic aging 
(environmental factors) [2]. Benchmarks and wrinkles are the combination from ultraviolet (UV) light and poor 
lifestyle to accelerate the skin depression [2,3]. Ultraviolet radiation (UVR) like UVB can penetrate to the 
epidermis, destructive the skin function and keratinocyte development [4]. UVA can induce ROS that caused 
DNA damage [5]. Mitogen-activated protein kinase (MAPK) pathway activated by ROS and increasing MMP 
production that degrades collagen [6]. In this 21st century, antioxidant intake is increasing [7]. Fruits, vegetables, 
whole grains, and herbs are rich of antioxidants like vitamin C, vitamin E, carotenoids and phenolics [8].  
Antioxidant donates hydrogen atom or proton to free radical so that the oxidation process can be slowed down 
[9]. Bioactive compounds in the natural sources have been used widely in cosmeceuticals substance to prevent 
skin aging [10]. The antiaging activity plays a role in stimulating collagen synthesis useful for improving skin 
appearance by restoring skin firmness and elasticity [11]. Scutellarein, apigenin, linalool, ursolic acid, estragole 
are rich in Ocimum basilicum L. leaf, they have applied for tropical cream because of their antiaging and 
antioxidant activity [12,13,14]. Arterbery and his colleagues [15] reported that apigenin use in cosmetical 
products contributed to improving skin firmness and skin health. Gu and his colleagues [16] reported that 
scutellarein has antioxidant activity particularly as DPPH scavenging activity. The aim of this study was to 
investigate the potential of scutellarein and apigenin as antioxidant sources particularly as ABTS reducing 
activity and antiaging sources particularly as the collagenase inhibitor. 
2. Experimental Section 
Materials 
Materials used in this study are ABTS (Sigma A1888), Potassium persulfate, Distilled water, PBS 1x, 
Dimethylsulfoxide (DMSO), Scutellarein, Apigenin, N-[3-(2-Furyl)acryloyl]-leu-gly-Pro-Ala (FALGPA) 
(Sigma F5135), Collagenase from Clostridium histolyticum (Sigma C8051), Tricine, Calcium chloride, Sodium 
Chloride and Hydrochloric acid solution. 
Instrumentation 
Instruments used in this study are Multiscan Go Reader, Micropipette ((1-10 µl, 50- 200 µl, 100-1000 µl), Tips 
(1-10 µl, 50- 200 µl, 100-1000 µl), 96 well plate, Falcon tube (15 ml and 50 ml), Analytical Balance, Eppendorf 
tube 1.5 ml, Vortex, pH meter, Beaker glass, Spatula, and Incubator. 
2.1 ABTS Reducing Activity Assay 
Mix the ABTS 14 mM and potassium persulfate 4.9 mM with a volume ratio 1:1 for 12-16 hours in dark room 
at room temperature to produce ABTS solution. Add PBS 1X to the mixture until the solution’s absorbance was 
0,7 ± 0,02 at 745 nm wavelength. In brief, 2 µL various level of Scutellarein and Apigenin added to each well, 
then add 198 µL ABTS solution into the well. The absorbance was measured at 745 nm wavelength after the 
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plate incubated for 6 minutes at 37°C [17]. 
% 𝑺𝒄𝒂𝒗𝒆𝒏𝒈𝒊𝒏𝒈 =  
𝒄 − 𝒔
𝒄
 𝒙 𝟏𝟎𝟎% 
c: control absorbance (without sample), s: sample absorbance 
2.2 Collagenase Inhibitory Activity Assay 
The mixture consists of 30 µL sample (0.78-50 µg/mL), 10 µL collagenase from Clostridium histolyticum (0.1 
mg/mL) and 60 µL Tricine buffer (50 mM Tricine, 10 mM calcium chloride, 400 mM sodium chloride, pH 7.5) 
incubated for 20 minutes at 37°C.  After incubated for 20 minutes, add 20 µL FALGPA substrate (1 mM) into 
the mixture. Absorbance was measured at 335 nm wavelength [17]. 
% 𝐼𝑛ℎ𝑖𝑏𝑖𝑡𝑖𝑜𝑛 =  
𝑐 − 𝑠
𝑐
 𝑥 100% 
c: control absorbance (without sample) 
s: sample absorbance  
3. Result and Discussion 
3.1 ABTS Reducing Activity Assay 
From table 1 showed that at 50.00 µg/mL, the ABTS reducing activity of scutellarein was 99.02 ± 0.06, at 25.00 
µg/mL was 66.78 ± 2.99, at 12.50 µg/mL was 39.53 ± 1.88, at 6.25 µg/mL was 34.57 ± 4.94, at 3.13 µg/mL was 
31.36 ± 2.90, at 1.56 was 25.42 ± 2.56. at 50.00 µg/mL, the ABTS reducing activity of apigenin was 30.88 ± 
0.42, at 25.00 µg/mL was 16.93 ± 0.14, at 12.50 µg/mL was 10.42 ± 0.72, at 6.25 µg/mL was 4.26 ± 0.51, at 
3.13 µg/mL was 2.47 ± 0.25, at 1.56 was 0.55 ± 0.09. Table 1 indicated that an increase in the concentration 
level was directly proportional to the increase of the ABTS reducing activity. 
Table 1: ABTS reducing activity of scutellarein and apigenin 
Final concentration (µg/ml) Mean of ABTS reducing activity (%)  
Scutellarein Apigenin 
50.00 99.02 ± 0.06e 30.88 ±0.42e 
25.00 66.78 ± 2.99d 16.93 ± 0.14d 
12.50 39.53 ± 1.88c 10.42 ± 0.72c 
6.25 34.57 ± 4.94b,c 4.26 ± 0.51b 
3.13 31.36 ± 2.90a,b 2.47 ± 0.25a,b 
1.56 25.42 ± 2.56a 0.55 ± 0.09a 
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Data were presented as mean ± standard deviation. Different small letters in the same column are significant at P 
< 0.05 (Tukey HSD post hoc test). 
From table 2 showed the IC50 value of ABTS reducing activity from scutellarein (16.77 ± 0.15 µg/mL) was 
lower than apigenin (80.19 ± 0.99 µg/mL). The IC50 is the concentration of scutellarein and apigenin needed to 
reduce half of ABTS. Table 2 indicated that scutellarein needed 16.77 ± 0.15 µg/mL and apigenin needed 80.19 
± 0.99 µg/mL to reduce ABTS activity. Based on the result indicated that scutellarein had ABTS reducing 
activity higher than apigenin. 
Table 2: IC50 value of ABTS reducing activity of scutellarein and apigenin 
Sample Equation R2 IC50 (µg/mL) IC50 (µg/mL) 
Scutellarein (1st repetition) Y = 1.5219x + 24.292 0.98 16.89 
16.77 ± 0.15 
Scutellarein (2nd repetition) Y = 1.5369x + 24.474 0.97 16.61 
Scutellarein (3rd repetition) Y = 1.4843x + 25.038 0.99 16.82 
Scutellarein (mean) Y = 1.5144x + 24.601 0.98 16.77 
Apigenin (1st repetition) Y = 0.6104x + 1.0496 0.98 80.19 
80.19 ± 0.99 
Apigenin (2nd repetition) Y = 0.6108x + 0.7413 0.99 80.65 
Apigenin (3rd repetition) Y = 0.6269x + 0.6366 0.99 78.74 
Apigenin (mean) Y = 0.616x + 0.8091 0.99 80.19 
 
The IC50 was used to classified antioxidant activity of scutellarein and apigenin. If the IC50 less than 50 µg/mL is 
very strong antioxidant, 50-100 µg/mL is a strong antioxidant, 101-150 µg/mL is a moderate antioxidant, over 
than 150 µg/mL is a weak antioxidant [3]. Li and his colleagues [18] reported that the IC50 value of scutellarein 
was 18.3 ± 1.2 µM, which indicated that scutellarein has very strong antioxidant activity. Martinez and his 
colleagues [19] reported that the IC50 value of apigenin was 379.7 µg/mL, which indicated that apigenin isolated 
from Alchornea coelophylla pax & k. Hoffm. leaf extract has weak antioxidant activity.  From the study, 
scutellarein has antioxidant activity through ABTS reducing activity higher than apigenin. Apigenin plays a 
major role in protecting cells from the breakdown of DNA double-stranded caused by oxidative stress [20]. 
Scutellarein plays a role in transferred electron to quench the free radical and reduced the activity [18]. 
3.2 Collagenase inhibitory activity assay 
From table 3 showed that at 250 µg/mL, the collagenase inhibitory activity of scutellarein was 92.83 ± 0.37, at 
125 µg/mL was 60.63 ± 1.47, at 62.5 µg/mL was 50.57 ± 1.92, 31.25 µg/mL was 26.78 ± 0.54, at 15.625 was 
20.29 ± 1.00, at 7.8125 was 17.18 ± 0.18 At 250 µg/mL, the collagenase inhibitory activity of apigenin was 
54.05 ± 7.98, at 125 µg/mL was 42.71± 0.31, at 62.5 µg/mL was 33.41 ± 0.50, 31.25 µg/mL was 29.48 ± 1.83, 
at 15.625 was 25.12 ± 1.17, at 7.8125 was 21.10 ± 0.06. Table 3 indicated that an increase in the concentration 
level was directly proportional to the increase of the collagenase inhibitory activity. 
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Table 3: Anti-collagenase activity of scutellarein and apigenin 
Final concentration (ug/ml) Mean of collagenase inhibitory activity (%)  
Scutellarein Apigenin 
250 92.83±0.37f 54.05±7.98d 
125 60.63±1.47e 42.71±0.31c 
62.5 50.57±1.92d 33.41±0.50b 
31.25 26.78±0.54c 29.48±1.83ab 
15.625 20.29±1.00b 25.12±1.17ab 
7.8125 17.18±0.18a 21.10±0.06a 
Data were presented as mean ± standard deviation. Different small letters in the same column are significant at P 
< 0.05 (Tukey HSD post hoc test). From table 4 showed the IC50 value of collagenase inhibitory activity from 
scutellarein (99.20 ± 0.94 µg/mL) was lower apigenin (211.67 ± 46.81 µg/mL). the IC50 is the concentration of 
scutellarein and apigenin needed to inhibit half of collagenase. Table 4 indicated that scutellarein needed 99.20 
± 0.94 µg/mL and apigenin needed 211.67 ± 46.81 µg/mL to inhibit collagenase activity. Based on the result 
indicated that scutellarein had collagenase inhibitory activity higher than apigenin. 
Table 4: IC50 value of anti-collagenase from scutellarein and apigenin 
Sample Equation R2 
IC50 
(µg/mL) 
IC50 
(µg/mL) 
Scutellarein (1st repetition) Y = 0.3061x + 19.46 0.96 99.77 
99.20 ± 0.94 
Scutellarein (2nd repetition) Y = 0.309x + 19.685 0.94 98.11 
Scutellarein (3rd repetition) Y = 0.3091x + 19.179 0.94 99.71 
Scutellarein (mean) Y = 0.3081x + 19.441 0.95 99.19 
Apigenin (1st repetition) Y = 0.1536x + 22.724 0.98 177.58 
211.67 ± 46.81 
Apigenin (2nd repetition) Y = 0.0921x + 25.59 0.80 265.04 
Apigenin (3rd repetition) Y = 0.1407x + 22.93 0.98 192.40 
Apigenin (mean) Y = 0.1288x + 23.748 0.95 203.82 
The IC50 was used to classified anti-collagenase activity of scutellarein and apigenin. If the IC50 less than 50 
µg/mL is very strong anti-collagenase, 50-100 µg/mL is a strong anti-collagenase, 101-150 µg/mL is a moderate 
anti-collagenase, over than 150 µg/mL is a weak anti-collagenase [3] Kristina and his colleagues [21] reported 
that the IC50 value of lycopene was 85.09 ± 1.81 µg/mL, which indicated that lycopene has strong anti-
collagenase activity. Widowati and his colleagues [22] reported that the IC50 value of myricetin was 11.65 ± 
2.08 µg/mL, which indicated that myricetin has very strong antioxidant. From our finding, that bioactive 
compounds did not always have strong anti-collagenase activity. According to Arterbery and his colleagues [23] 
in tropical products apigenin improve firmness, elasticity, maintain hydration, decrease MMP-1 and MMP-2 
production. The bioactive compound can boost the collagen synthesis and reduce the collagenase activity 
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through the collagen breakdown [21]. Clinical application of the present study is to investigate the antiaging 
effect of scutellarein in topical product compared with apigenin. 
4. Conclusions  
Scutellarein has very strong antioxidant activity through ABTS reduction activity and strong antiaging activity 
particularly as collagenase inhibitor, apigenin has strong antioxidant activity through ABTS reduction activity 
and weak antiaging property particularly as collagenase inhibitor. Scutellarein has antioxidant activity through 
ABTS reduction activity and antiaging activity through collagenase inhibitory activity better than apigenin. 
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